Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model
<i>ZNF330</i> and <i>PITPNM</i> are the eKDEGs for PRAD, which can be used as potential new prognostic markers. The two-factor combined risk model can effectively assess the survival and prognosis of PRAD patients, but also can predict the different responses of immunotherapy to PRAD patients, which may provide new ideas for PRAD immunotherapy.
Authors
- Qingliu He
- Qingfu Su
- Wei Zhuang (ORCID: https://orcid.org/0009-0008-9907-1576)
- Chengcheng Wei (ORCID: https://orcid.org/0000-0002-6634-0572)
- Pu Zhang (ORCID: https://orcid.org/0009-0000-3360-9937)
- Junyi Chen (ORCID: https://orcid.org/0009-0005-1280-2451)
- Weihui Liu (ORCID: https://orcid.org/0000-0003-2871-8316)
- Xiaoping Su
Institutions
- Fujian Medical University (CN)
- University of Electronic Science and Technology of China (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-17
- DOI
- https://doi.org/10.3389/fphar.2024.1464145
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28